James Denvir
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Molecular Biology Techniques and Applications
Papers in
-
- Cancer-related molecular mechanisms research 6
- Cancer, Hypoxia, and Metabolism 6
- Co-authors
- Donald A. PrimeranoSteven M. FrischBenjamin CieplyTerry W. FengerJoshua C. FarrisPhillip M. PiferHeide L. FordGoran Bošković
- Journals
- PLoS ONE (4 papers)Scientific Reports (4 papers)Cancer Research (3 papers)International Journal of Molecular Sciences (3 papers)Biochemical Pharmacology (3 papers)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
James Denvir
61 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 141
- Cancer Research 269
- Molecular Biology 774
- Oncology 286
- Biological Psychiatry 21
- Genetics 157
Countries citing papers authored by James Denvir
This map shows the geographic impact of James Denvir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Denvir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Denvir more than expected).
Fields of papers citing papers by James Denvir
This network shows the impact of papers produced by James Denvir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Denvir. The network helps show where James Denvir may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James Denvir, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 4 | |
| 3 | 2022 | 25 | |
| 4 | 2021 | 6 | |
| 5 | 2021 | 10 | |
| 6 | 2020 | 7 | |
| 7 | 2020 | 16 | |
| 8 | 2019 | 10 | |
| 9 | 2018 | 29 | |
| 10 | 2016 | 30 | |
| 11 | 2016 | 14 | |
| 12 | 2015 | 10 | |
| 13 | 2014 | 23 | |
| 14 | 2014 | 40 | |
| 15 | 2013 | 151 | |
| 16 | 2012 | 168 | |
| 17 | 2012 | 66 | |
| 18 | 2009 | 19 | |
| 19 | 2009 | 9 | |
| 20 | 2004 | 87 |
About James Denvir
James Denvir is a scholar working on Cancer Research, Health Informatics, Molecular Biology, Immunology and Genetics, having authored 65 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (6 papers), Cancer-related molecular mechanisms research (6 papers), Cancer, Hypoxia, and Metabolism (6 papers), Cancer-related Molecular Pathways (4 papers), Molecular Biology Techniques and Applications (4 papers), Adipose Tissue and Metabolism (4 papers), Gene expression and cancer classification (4 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Cancer Research (269 citations), Molecular Biology (774 citations), Oncology (286 citations), Biological Psychiatry (21 citations) and Genetics (157 citations). James Denvir has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Donald A. Primerano, Steven M. Frisch, Benjamin Cieply, Terry W. Fenger, Joshua C. Farris, Phillip M. Pifer, Heide L. Ford, Goran Bošković, Nancy Lan Guo and Joseph Addison. Their work appears in journals such as PLoS ONE, Scientific Reports, Cancer Research, International Journal of Molecular Sciences and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.